4.7 Article

Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation A randomized, double-blind, placebo-controlled, crossover, 32-week study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Ophthalmology

Intravitreal Administration of the Anti-Tumor Necrosis Factor Agent Infliximab for Neovascular Age-related Macular Degeneration

Panagiotis G. Theodossiadis et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)

Review Endocrinology & Metabolism

Advances in the Medical Treatment of Diabetic Retinopathy

Rafael Simo et al.

DIABETES CARE (2009)

Article Ophthalmology

Intravitreal administration of the anti-TNF monoclonal antibody Infliximab in the rabbit

Panagiotis G. Theodossiadis et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)

Article Ophthalmology

Intravitreal Infliximab Clearance in a Rabbit Model: Different Sampling Methods and Assay Techniques

Fabrizio Giansanti et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)

Review Ophthalmology

Interventions for diabetic macular oedema: a systematic review of the literature

M. O'Doherty et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2008)

Review Immunology

Immunological mechanisms in the pathogenesis of diahetic retinopathy

Anthony P. Adamis et al.

SEMINARS IN IMMUNOPATHOLOGY (2008)

Review Ophthalmology

Tumor necrosis factor antagonists - Preliminary evidence for an emerging approach in the treatment of ocular inflammation

Panagiotis G. Theodossiadis et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)

Article Biochemistry & Molecular Biology

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

AM Joussen et al.

FASEB JOURNAL (2002)